Company Announcements

Directorate Change

Source: RNS
RNS Number : 5643J
Frenkel Topping Group PLC
25 October 2024
 

Frenkel Topping Group plc

("Frenkel Topping", the "Company" or the "Group") 

 

Directorate Change

 

 

Frenkel Topping (AIM: FEN), a specialist financial and professional services firm operating within the personal injury and clinical negligence marketplace (PI and CN) announces that Zoe Holland MBE has, by mutual agreement, resigned from the Board as Non-Executive Director with immediate effect to free up Zoe's capacity to focus on new opportunities.

 

The Group intends to seek a replacement for Zoe and shall make a further announcement once a suitable candidate has been identified, whom we hope will add as much value to the Group as Zoe has done.

 

Chief Executive Officer, Richard Fraser, said:

"I would like to thank Zoe for her considerable contribution to Frenkel Topping during an important period of evolution and growth for the Group, and especially for her role in bringing us together with Cardinal Management. Her M&A experience in the legal sector has been invaluable. On behalf of the Frenkel Topping team, I would like to wish Zoe every success and as a management team we will draw on Zoe's experience in a more consultative capacity."

 

Zoe Holland MBE said:

"It has been an exciting period to be part of Frenkel Topping. The Group has grown considerably through several key acquisitions. It has been highly rewarding to have been part of the growth journey, particularly the acquisition of Cardinal Management. I look forward to seeing the Group go from strength to strength."

 

 

For further information: 

Frenkel Topping Group plc

www.frenkeltoppinggroup.co.uk

Richard Fraser, Chief Executive Officer

Tel: 0161 886 8000



Cavendish Capital Markets Limited (Nominated Advisor & Broker)

Tel: 020 7220 0500

Carl Holmes/Abigail Kelly (Corporate Finance)

 Tim Redfern (ECM)


 

About Frenkel Topping Group

The Frenkel Topping Group of companies specialises in providing financial advice and asset protection services to clients at times of financial vulnerability, with particular expertise in the field of personal injury (PI) and clinical negligence (CN).

For more than 30 years the Group has worked with legal professionals and injured clients themselves to provide pre-settlement, at-settlement and post-settlement services to help achieve the best long-term outcomes for clients after injury. It boasts a client retention rate of 99%.

Frenkel Topping Group is focused on consolidating the fragmented PI and CN space in order to provide the most comprehensive suite of services to clients and deliver a best-in-class service offering from immediately after injury or illness and for the rest of their lives.

The group's services include the Major Trauma Signposting Partnership service inside NHS Major Trauma Centres, expert witness, costs, tax and forensic accountancy, independent financial advice, investment management, and care and case management.

The Group's discretionary fund manager, Ascencia, manages financial portfolios for clients in unique circumstances, often who have received a financial settlement after litigation. In recent years Ascencia has diversified its portfolios to include a Sharia-law-compliant portfolio and a number of ESG portfolios in response to increased interest in socially responsible investing (SRI).

Frenkel Topping has earned a reputation for commercial astuteness underpinned by a strong moral obligation to its clients, employees and wider society, with a continued focus on its Environmental, Social and Governance (ESG) impact.

For more information visit:      www.frenkeltoppinggroup.co.uk

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAKZMZGLDGGDZM